Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CBLB | Q13191 | 2/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.36 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.36 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.35 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1628096 | 1.00 | APEX1 (0.42) | APEX1ACHEKMT2AATMSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL233973 | 0.98 | APEX1 (0.41) | APEX1ACHEKMT2AATMSMN1; SMN2 | |
| Sulfuric Acid SCHEMBL25230184 | 0.93 | APEX1 (0.42) | APEX1ACHEKMT2AATMSMN1; SMN2 | |
| SCHEMBL20530938 | 0.88 | ACHE (0.50) | APEX1ACHEKMT2AATMSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL8777430 | 0.86 | ACHE (0.49) | APEX1ACHEKMT2AATMSMN1; SMN2 | |
| Trifluoromethanesulfonic Acid SCHEMBL25407679 | 0.86 | APEX1 (0.38) | APEX1ACHEKMT2AATMSMN1; SMN2 | |
| SCHEMBL21610956 | 0.83 | APEX1 (0.49) | APEX1KMT2ASMN1; SMN2ALDH1A1TAAR1 | |
| SCHEMBL19971710 | 0.83 | APEX1 (0.37) | APEX1ACHEKMT2AATMSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL11054825 | 0.82 | KMT2A (0.42) | APEX1KMT2AATMSMN1; SMN2ALDH1A1 | |
| SCHEMBL19971715 | 0.82 | APEX1 (0.39) | APEX1ACHEKMT2AATMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11833475-B2 | Filtering device, purification device, and method for manufacturing chemical liquid | FUJIFILM CORPORATION (JP) | 2023-12-05 | — | — | US | disclosed |
| US-20230175195-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | MOLECULAR PLASMA GROUP S.A. (LU) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230175195-A1 | PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER | TFPI, TTPA, CD4 | APEX1 480/4885ACHE 4630/4885KMT2A 3483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.